Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

Inhibition of hedgehog signaling improves the anti-carcinogenic effects of docetaxel in prostate cancer.

Mimeault M, Rachagani S, Muniyan S, Seshacharyulu P, Johansson SL, Datta K, Lin MF, Batra SK.

Oncotarget. 2015 Feb 28;6(6):3887-903.

2.

Molecular biomarkers of cancer stem/progenitor cells associated with progression, metastases, and treatment resistance of aggressive cancers.

Mimeault M, Batra SK.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):234-54. doi: 10.1158/1055-9965.EPI-13-0785. Epub 2013 Nov 22. Review.

3.

Introduction at the special issue on implications of cancer stem/progenitor cell concepts in molecular oncology and novel targeted therapies.

Mimeault M, Batra SK.

Mol Aspects Med. 2014 Oct;39:1-2. doi: 10.1016/j.mam.2013.09.001. Epub 2013 Sep 27. No abstract available.

PMID:
24080440
4.

Altered gene products involved in the malignant reprogramming of cancer stem/progenitor cells and multitargeted therapies.

Mimeault M, Batra SK.

Mol Aspects Med. 2014 Oct;39:3-32. doi: 10.1016/j.mam.2013.08.001. Epub 2013 Aug 29. Review.

5.

Development of animal models underlining mechanistic connections between prostate inflammation and cancer.

Mimeault M, Batra SK.

World J Clin Oncol. 2013 Feb 10;4(1):4-13. doi: 10.5306/wjco.v4.i1.4.

6.
7.

Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.

Mimeault M, Batra SK.

J Cell Mol Med. 2013 Jan;17(1):30-54. doi: 10.1111/jcmm.12004. Epub 2013 Jan 10.

8.

Emergence of zebrafish models in oncology for validating novel anticancer drug targets and nanomaterials.

Mimeault M, Batra SK.

Drug Discov Today. 2013 Feb;18(3-4):128-40. doi: 10.1016/j.drudis.2012.08.002. Epub 2012 Aug 10. Review.

9.

Adsorption study of a commonly used antidepressant drug, fluoxetine hydrochloride, onto a crosslinked β-cyclodextrin-carboxymethylcellulose polymer.

Bonenfant D, Mimeault M, Niquette P, Hausler R.

Water Sci Technol. 2012;66(1):224-30. doi: 10.2166/wst.2012.112.

PMID:
22678222
10.

Great promise of tissue-resident adult stem/progenitor cells in transplantation and cancer therapies.

Mimeault M, Batra SK.

Adv Exp Med Biol. 2012;741:171-86. doi: 10.1007/978-1-4614-2098-9_12. Review.

11.

Novel biomarkers and therapeutic targets for optimizing the therapeutic management of melanomas.

Mimeault M, Batra SK.

World J Clin Oncol. 2012 Mar 10;3(3):32-42. doi: 10.5306/wjco.v3.i3.32.

12.

Pathobiological implications of the expression of EGFR, pAkt, NF-κB and MIC-1 in prostate cancer stem cells and their progenies.

Mimeault M, Johansson SL, Batra SK.

PLoS One. 2012;7(2):e31919. doi: 10.1371/journal.pone.0031919. Epub 2012 Feb 23.

13.

Synthesis and structure-activity study of quaternary ammonium functionalized beta-cyclodextrin-carboxymethylcellulose polymers.

Bonenfant D, Bourgeois FR, Mimeault M, Monette F, Niquette P, Hausler R.

Water Sci Technol. 2011;63(12):2827-32.

PMID:
22049706
14.
15.
16.
17.

Animal models relevant to human prostate carcinogenesis underlining the critical implication of prostatic stem/progenitor cells.

Mimeault M, Batra SK.

Biochim Biophys Acta. 2011 Aug;1816(1):25-37. doi: 10.1016/j.bbcan.2011.03.001. Epub 2011 Mar 17. Review.

19.

Divergent molecular mechanisms underlying the pleiotropic functions of macrophage inhibitory cytokine-1 in cancer.

Mimeault M, Batra SK.

J Cell Physiol. 2010 Sep;224(3):626-35. doi: 10.1002/jcp.22196. Review.

20.
21.

Adsorption and recovery of nonylphenol ethoxylate on a crosslinked beta-cyclodextrin-carboxymethylcellulose polymer.

Bonenfant D, Niquette P, Mimeault M, Hausler R.

Water Sci Technol. 2010;61(9):2293-301. doi: 10.2166/wst.2010.152.

PMID:
20418626
22.
23.

New promising drug targets in cancer- and metastasis-initiating cells.

Mimeault M, Batra SK.

Drug Discov Today. 2010 May;15(9-10):354-64. doi: 10.1016/j.drudis.2010.03.009. Epub 2010 Mar 23. Review.

24.

MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progenies.

Mimeault M, Johansson SL, Senapati S, Momi N, Chakraborty S, Batra SK.

Cancer Lett. 2010 Sep 1;295(1):69-84. doi: 10.1016/j.canlet.2010.02.015. Epub 2010 Mar 19.

26.

Cytotoxic effects induced by docetaxel, gefitinib, and cyclopamine on side population and nonside population cell fractions from human invasive prostate cancer cells.

Mimeault M, Johansson SL, Henichart JP, Depreux P, Batra SK.

Mol Cancer Ther. 2010 Mar;9(3):617-30. doi: 10.1158/1535-7163.MCT-09-1013. Epub 2010 Feb 23.

27.

Aging of tissue-resident adult stem/progenitor cells and their pathological consequences.

Mimeault M, Batra SK.

Panminerva Med. 2009 Jun;51(2):57-79. Review.

PMID:
19776709
28.

Recent advances on skin-resident stem/progenitor cell functions in skin regeneration, aging and cancers and novel anti-aging and cancer therapies.

Mimeault M, Batra SK.

J Cell Mol Med. 2010 Jan;14(1-2):116-34. doi: 10.1111/j.1582-4934.2009.00885.x. Epub 2009 Sep 1. Review.

29.

Characterization of nonmalignant and malignant prostatic stem/progenitor cells by Hoechst side population method.

Mimeault M, Batra SK.

Methods Mol Biol. 2009;568:139-49. doi: 10.1007/978-1-59745-280-9_8.

PMID:
19582424
30.

UV-VIS and FTIR spectroscopic analyses of inclusion complexes of nonylphenol and nonylphenol ethoxylate with beta-cyclodextrin.

Bonenfant D, Niquette P, Mimeault M, Furtos-Matei A, Hausler R.

Water Res. 2009 Aug;43(14):3575-81. doi: 10.1016/j.watres.2009.05.010. Epub 2009 May 19.

PMID:
19541340
31.

Recent insights into the molecular mechanisms involved in aging and the malignant transformation of adult stem/progenitor cells and their therapeutic implications.

Mimeault M, Batra SK.

Ageing Res Rev. 2009 Apr;8(2):94-112. doi: 10.1016/j.arr.2008.12.001. Epub 2008 Dec 9. Review.

32.
35.

Improvement of cytotoxic effects induced by mitoxantrone on hormone-refractory metastatic prostate cancer cells by co-targeting epidermal growth factor receptor and hedgehog signaling cascades.

Mimeault M, Mehta PP, Hauke R, Henichart JP, Depreux P, Lin MF, Batra SK.

Growth Factors. 2007 Dec;25(6):400-16. doi: 10.1080/08977190801930935.

PMID:
18365871
36.

Advances in principal factors influencing carbon dioxide adsorption on zeolites.

Bonenfant D, Kharoune M, Niquette P, Mimeault M, Hausler R.

Sci Technol Adv Mater. 2008 Mar 25;9(1):013007. eCollection 2008 Jan.

37.

Functions of normal and malignant prostatic stem/progenitor cells in tissue regeneration and cancer progression and novel targeting therapies.

Mimeault M, Mehta PP, Hauke R, Batra SK.

Endocr Rev. 2008 Apr;29(2):234-52. doi: 10.1210/er.2007-0040. Epub 2008 Feb 21. Review.

38.

Recent progress on tissue-resident adult stem cell biology and their therapeutic implications.

Mimeault M, Batra SK.

Stem Cell Rev. 2008 Spring;4(1):27-49. doi: 10.1007/s12015-008-9008-2. Review.

39.
40.

Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies.

Mimeault M, Hauke R, Batra SK.

Clin Pharmacol Ther. 2008 May;83(5):673-91. Epub 2007 Sep 5. Review.

41.
42.
44.
45.

Novel combination therapy against metastatic and androgen-independent prostate cancer by using gefitinib, tamoxifen and etoposide.

Mimeault M, Venkatraman G, Johansson SL, Moore E, Henichart JP, Depreux P, Lin MF, Batra SK.

Int J Cancer. 2007 Jan 1;120(1):160-9.

46.

Concise review: recent advances on the significance of stem cells in tissue regeneration and cancer therapies.

Mimeault M, Batra SK.

Stem Cells. 2006 Nov;24(11):2319-45. Epub 2006 Jun 22. Review.

47.

Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies.

Mimeault M, Brand RE, Sasson AA, Batra SK.

Pancreas. 2005 Nov;31(4):301-16. Review.

PMID:
16258363
48.

Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.

Mimeault M, Batra SK.

Carcinogenesis. 2006 Jan;27(1):1-22. Epub 2005 Sep 29. Review.

PMID:
16195239
49.

Supplemental Content

Loading ...
Support Center